Having trouble viewing this email? View in a browser.

You are subscribed to Formulary. Unsubscribe.

Formulary

Formulary News Capsule

FormularyJournal.com

June 15, 2012

CLINICAL NEWS

Study: Unintentional overdose on OTC acetaminophen linked to limited literacy, heavy usage

In a recent study, researchers find reasons why a significant number of US adults are at risk of unintentionally overdosing on over-the-counter pain medications. » More

CONTINUING EDUCATION

Psychopharmacology for the elderly

Late-life depression can occur in up to 50% of patients. Pharmacists can screen for unidentified cases and advocate for routine measurement of symptom severity.

To read and print the article with TEST QUESTIONS, click here. To proceed to the online exams and earn up to 2 CPE credits, click here to login.

ADVERTISEMENT

New Drug Price Type Options: White Paper

Two new and different methods to ascertain true drug acquisition cost can save money on Rx drug benefits. Read white paper for details and comparison of NADAC and PAC.

EDITOR’S PICK

Multiple sclerosis

Read about pharmaceuticals in late-stage development for the treatment of multiple sclerosis, as well as view selected literature and websites that provide the latest information about the disease. » Click here.

CLINICAL NEWS

NSAIDs may prevent skin cancer, study suggests

Nonsteroidal anti-inflammatory drugs may prevent the development of skin cancer, according to a new study, published online first in the journal Cancer on May 29. » More

Afatinib used in lung cancer treatment helps patients live longer, results show

Investigational afatinib used in non-small cell lung cancer treatment helped patients live longer compared with pemetrexed/cisplatin, according to the results of a new phase 3 clinical trial. » More

New data shows better QOL with enzalutamide for men with advanced prostate cancer

Men with advanced prostate cancer treated with investigational enzalutamide (formerly MDV3100) demonstrated a significantly higher response rate in health-related quality of life compared with placebo, according to new data from the phase 3 AFFIRM study. » More

Survey

Based upon your experience with Medication Therapy Management (MTM) programs and services to date, how would you assess their impact in improving healthcare quality and lowering healthcare costs in their targeted patient population?

a) Highly effective
b) Somewhat effective
c) Neutral
d) Somewhat ineffective
e) Largely ineffective

Click here and see what your colleagues think, too.

Want to see the results of our last survey about specialty pharmacy services? Click here.

Twitter  

Follow us on Twitter

Facebook  

Like us on Facebook

Resources

Drug Watch

FDA Actions

Latest News

Medication Safety

Policy Watch

Digital Edition

View current edition

Cover
 
Powered by Modern Medicine Advanstar Medical Communications Group